Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion
Sponsor
Medical University of Vienna (Other)
Overall Status
Completed
CT.gov ID
NCT03766828
Collaborator
(none)
36
1
21.9
1.6
Study Details
Study Description
Brief Summary
A unique inside-out-access technique with a new CE certified device (Surfacer (R) Bluegrass Vascular, San Antonio, Tx, USA) enables repetitive and confident right-sided placement of central venous catheters in hemodialysis patients with thoracic central venous occlusion.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
36 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion
Actual Study Start Date
:
Sep 1, 2016
Actual Primary Completion Date
:
Jun 30, 2018
Actual Study Completion Date
:
Jun 30, 2018
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
inside-out-access technique with inside-out access device
|
Procedure: inside-out-access technique with inside-out access device (Surfacer (R))
inside-out-access technique with (Surfacer (R)) with a new CE certified device (Surfacer (R), Bluegrass Vascular)
|
access technique including Sharp recanalization
|
Procedure: access technique including Sharp recanalization
access technique with Sharp recanalization via interventional radiology
|
Outcome Measures
Primary Outcome Measures
- Achievement of dialysis access [1 day]
Secondary Outcome Measures
- procedure related complications [3 months]
infections, bleeding, hematoma or pericardial effusions and intervention related parameters
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patients with thoracic central venous occlusion
Exclusion Criteria:
- pregnancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna | Vienna | Austria | 1180 |
Sponsors and Collaborators
- Medical University of Vienna
Investigators
- Principal Investigator: Gürkan Sengölge, Department of Medicine III, Division of Nephrology
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Guerkan SENGOELGE,
Assoc. Prof. Priv.-Doz. Dr.,
Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT03766828
Other Study ID Numbers:
- Vienna-DialysisAccess
First Posted:
Dec 6, 2018
Last Update Posted:
May 29, 2019
Last Verified:
May 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Guerkan SENGOELGE,
Assoc. Prof. Priv.-Doz. Dr.,
Medical University of Vienna
Additional relevant MeSH terms: